Thursday, June 26, 2025 9:37:13 AM
XMaster2023, great assessment for Flaskworks.
The latest Flaskworks devices have been tested and validated as effective devices for vaccine production, case in point Eagle8 post# 772913, IMPO.
Over the past few years, I have been studying multiple patents for the Flaskworks devices since the initial Flaskworks US patent release.
Here are some additional comments that support the Flaskworks devices as I see them,
1) The Flaskworks devices are designed to be adaptive and upgraded on the fly. In other words, each Flaskworks device has several key components such as a microprocessor, network interface communications port, and software programmable hardware for field updates as needed, IMPO.
2) The Flaskworks devices are closed loop system that is designed to minimize the need for higher level expensive clean rooms, saving costs, IMPO.
https://www.cleanroomsbyunited.com/industries?utm_source=bing&utm_medium=cpc&utm_campaign=Clean%20Rooms%20by%20UNITED&utm_term=Manufacturing%20Clean%20Rooms&utm_source=bing&utm_medium=cpc&utm_campaign=&utm_content=&utm_term=Manufacturing%20Clean%20Rooms&ran=oBX&msclkid=8423851f77231ae91063ed4233b3fbdf
https://www.belcherequipment.com/cleanroom-systems/cleanroom-design-and-configuration/legend-cleanroom-systems-and-standards?msclkid=5a0377133f9717d4d0071f4e7b073327
3) The Flaskworks devices are difficult to replicate based on FPGA Field Programmable Gate Array technology using encryption to prevent reverse engineering, IMPO.
4) Since each of the Flaskworks devices have individual communication ports, every Flaskworks device can be controlled by a central computer network for advance communications, software updates, statistical manufacturing monitoring for quality control and more, IMPO. In addition, since each Flaskworks device has an advanced manufacturing capability, this will enable multiple manufacturing facilities to utilize the Flaskworks devices as long as each manufacturing facility passes inspections for specific production capabilities, IMPO
5) With the lates advancement in AI, Artificial Intelligence software, each Flaskworks devices can be fine tuning for optimal performance capabilities. This would allow the manufacturing teams not only to maximize production, increase quality and allow each manufacturing team to provide feedback to all other manufacturing teams as well, IMPO.
In all, the current Flaskworks device are a blessing as they are able to reduce human errors, they will continue to be adaptive in their performance capabilities no matter where they are used all over the world, IMPO
The key is manufacturing, manufacturing and the Flaskworks devices are the gateway to volume production, quality, and a host of other manufacturing capabilities to advance the overall vaccine production process. Last, many cancer patients will reap the benefits the Flaskworks devices, IMPO
The latest Flaskworks devices have been tested and validated as effective devices for vaccine production, case in point Eagle8 post# 772913, IMPO.
Over the past few years, I have been studying multiple patents for the Flaskworks devices since the initial Flaskworks US patent release.
Here are some additional comments that support the Flaskworks devices as I see them,
1) The Flaskworks devices are designed to be adaptive and upgraded on the fly. In other words, each Flaskworks device has several key components such as a microprocessor, network interface communications port, and software programmable hardware for field updates as needed, IMPO.
2) The Flaskworks devices are closed loop system that is designed to minimize the need for higher level expensive clean rooms, saving costs, IMPO.
https://www.cleanroomsbyunited.com/industries?utm_source=bing&utm_medium=cpc&utm_campaign=Clean%20Rooms%20by%20UNITED&utm_term=Manufacturing%20Clean%20Rooms&utm_source=bing&utm_medium=cpc&utm_campaign=&utm_content=&utm_term=Manufacturing%20Clean%20Rooms&ran=oBX&msclkid=8423851f77231ae91063ed4233b3fbdf
https://www.belcherequipment.com/cleanroom-systems/cleanroom-design-and-configuration/legend-cleanroom-systems-and-standards?msclkid=5a0377133f9717d4d0071f4e7b073327
3) The Flaskworks devices are difficult to replicate based on FPGA Field Programmable Gate Array technology using encryption to prevent reverse engineering, IMPO.
4) Since each of the Flaskworks devices have individual communication ports, every Flaskworks device can be controlled by a central computer network for advance communications, software updates, statistical manufacturing monitoring for quality control and more, IMPO. In addition, since each Flaskworks device has an advanced manufacturing capability, this will enable multiple manufacturing facilities to utilize the Flaskworks devices as long as each manufacturing facility passes inspections for specific production capabilities, IMPO
5) With the lates advancement in AI, Artificial Intelligence software, each Flaskworks devices can be fine tuning for optimal performance capabilities. This would allow the manufacturing teams not only to maximize production, increase quality and allow each manufacturing team to provide feedback to all other manufacturing teams as well, IMPO.
In all, the current Flaskworks device are a blessing as they are able to reduce human errors, they will continue to be adaptive in their performance capabilities no matter where they are used all over the world, IMPO
The key is manufacturing, manufacturing and the Flaskworks devices are the gateway to volume production, quality, and a host of other manufacturing capabilities to advance the overall vaccine production process. Last, many cancer patients will reap the benefits the Flaskworks devices, IMPO
Bullish
Recent NWBO News
- Northwest Biotherapeutics Appoints Dr. Annalisa Jenkins As Strategic Adviser To Advance Dendritic Cell Cancer Vaccine Platform • PR Newswire (US) • 04/30/2026 04:38:00 PM
- Northwest Biotherapeutics Appoints Dr. Annalisa Jenkins As Strategic Adviser To Advance Dendritic Cell Cancer Vaccine Platform • PR Newswire (US) • 04/30/2026 04:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 04/21/2026 04:15:08 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 04/16/2026 09:25:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 04:30:50 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2026 09:04:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
